Explore more publications!
Idaho Healthcare Hub
Submit Press Release

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 14, 2025

Boise Chiropractor Dr. Jamie Ricks D.C. Offers Natural Solutions for Pickleball Injuries at Advantage Spine and Disc
October 14, 2025

Boise Chiropractor Dr. Jamie Ricks D.C. Offers Natural Solutions for Pickleball Injuries at Advantage Spine and Disc

Indeterminate EIN Presswire
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
October 14, 2025

Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma

Indeterminate GlobeNewswire
EyePoint Announces Proposed Public Offering of Common Stock
October 14, 2025

EyePoint Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
PetMeds® Files Form 10-K for Fiscal 2025
October 14, 2025

PetMeds® Files Form 10-K for Fiscal 2025

Indeterminate GlobeNewswire
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq
October 14, 2025

WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq

Indeterminate GlobeNewswire
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
October 14, 2025

Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21

Indeterminate GlobeNewswire
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
October 14, 2025

Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference

Indeterminate GlobeNewswire
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema
October 14, 2025

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

Indeterminate GlobeNewswire
Inventiva Announces the Implementation of a New ATM Program
October 14, 2025

Inventiva Announces the Implementation of a New ATM Program

Indeterminate GlobeNewswire
Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)
October 14, 2025

Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)

Indeterminate GlobeNewswire
Oral GLP-1 Tablets Gain Momentum as Telehealth Platform MEDVi Expands Access to Compounded Semaglutide and Tirzepatide for Physician-Supervised Weight Management
October 14, 2025

Oral GLP-1 Tablets Gain Momentum as Telehealth Platform MEDVi Expands Access to Compounded Semaglutide and Tirzepatide for Physician-Supervised Weight Management

Indeterminate GlobeNewswire
Op de AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics kondigt Merus de publicatie aan van het abstract over petosemtamab in gemetastaseerde colorectale kanker
October 14, 2025

Op de AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics kondigt Merus de publicatie aan van het abstract over petosemtamab in gemetastaseerde colorectale kanker

Indeterminate GlobeNewswire
Lung Cancer Antibody Drug Conjugates Market Size FDA Approved Lung Cancer ADC Clinical Trials Future Opportunity Insight
October 14, 2025

Lung Cancer Antibody Drug Conjugates Market Size FDA Approved Lung Cancer ADC Clinical Trials Future Opportunity Insight

Indeterminate GlobeNewswire
EmblemHealth Achieves 4-Star Medicare Rating, Highlighting Sustained Quality Improvements
October 14, 2025

EmblemHealth Achieves 4-Star Medicare Rating, Highlighting Sustained Quality Improvements

Indeterminate GlobeNewswire
Breakthrough in Obesity Solutions: Fuzzle’s Non-Invasive Oral Device Begins FDA Review Process
October 14, 2025

Breakthrough in Obesity Solutions: Fuzzle’s Non-Invasive Oral Device Begins FDA Review Process

Indeterminate GlobeNewswire
Lymphoma Antibody Drug Conjugates Treatment Market FDA Approved Drugs Clinical Trials Lymphoma ADC Market Opportunity Insight
October 14, 2025

Lymphoma Antibody Drug Conjugates Treatment Market FDA Approved Drugs Clinical Trials Lymphoma ADC Market Opportunity Insight

Indeterminate GlobeNewswire
CD40 Targeting Therapy Clinical Trials Anti CD40 Antibody Therapy Market Opportunity Assessment Insight
October 14, 2025

CD40 Targeting Therapy Clinical Trials Anti CD40 Antibody Therapy Market Opportunity Assessment Insight

Indeterminate GlobeNewswire
OX40 Targeted Therapy Clinical Trials Anti OX40 Antibody Development Market Opportunity Insight 2026
October 14, 2025

OX40 Targeted Therapy Clinical Trials Anti OX40 Antibody Development Market Opportunity Insight 2026

Indeterminate GlobeNewswire
Nova Leap Health Corp. to Highlight Record Q2 2025 Results at Planet MicroCap Showcase Toronto
October 14, 2025

Nova Leap Health Corp. to Highlight Record Q2 2025 Results at Planet MicroCap Showcase Toronto

Indeterminate GlobeNewswire
Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
October 14, 2025

Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions